News

The more we know, the more we achieve.

Our media.

Beta Bionics Announces iLet Bionic Pancreas is Now Added to the Express Scripts National Commercial Formularies

/
CONCORD, Mass., November 14, 2023: Beta Bionics, Inc., a pioneering…

Beta Bionics Secures $100 Million in Series D Funding to Advance Diabetes Technology and Expand Market Presence

/
CONCORD, Mass., August 30, 2023: Beta Bionics, Inc., a pioneering…

Beta Bionics Announces FDA Clearance and Commercialization of the iLet Bionic Pancreas

- First and only, automated insulin-delivery system that determines…

Beta Bionics Appoints Sean Saint as CEO and Board Member

Caution: The iLet® Bionic Pancreas and iLet Duo™ are investigational…

Pivotal Trial Results of the iLet® Bionic Pancreas To Be Presented at ATTD

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Announces Closing of $57 Million Series C Financing

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Announces Appointment of Christy Jones to Board of Directors

Irvine, CA – May 6, 2021 – Beta Bionics, Inc., a medical…

Beta Bionics appoints Beth Brooke to its Board as Independent Director

Concord, MA – December 30, 2020 – Beta Bionics, Inc. —…

Beta Bionics appoints Martha Aronson and Sean Carney to its Board as Independent Directors

West Concord, MA – February 20, 2020 – Beta Bionics, Inc.…

Beta Bionics awarded up to $2 million NIH small business innovation research (SBIR) grant

Award from the National Institute of Diabetes and Digestive…

Beta Bionics secures an initial $50 million Series B round

The round was led by Eventide Asset Management Other institutional…

Beta Bionics Announces iLet Bionic Pancreas is Now Added to the Express Scripts National Commercial Formularies

/
CONCORD, Mass., November 14, 2023: Beta Bionics, Inc., a pioneering…

Beta Bionics Secures $100 Million in Series D Funding to Advance Diabetes Technology and Expand Market Presence

/
CONCORD, Mass., August 30, 2023: Beta Bionics, Inc., a pioneering…

Beta Bionics Announces FDA Clearance and Commercialization of the iLet Bionic Pancreas

- First and only, automated insulin-delivery system that determines…

Beta Bionics Appoints Sean Saint as CEO and Board Member

Caution: The iLet® Bionic Pancreas and iLet Duo™ are investigational…

Pivotal Trial Results of the iLet® Bionic Pancreas To Be Presented at ATTD

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Announces Closing of $57 Million Series C Financing

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Announces Appointment of Christy Jones to Board of Directors

Irvine, CA – May 6, 2021 – Beta Bionics, Inc., a medical…

Beta Bionics appoints Beth Brooke to its Board as Independent Director

Concord, MA – December 30, 2020 – Beta Bionics, Inc. —…

Beta Bionics appoints Martha Aronson and Sean Carney to its Board as Independent Directors

West Concord, MA – February 20, 2020 – Beta Bionics, Inc.…

Beta Bionics awarded up to $2 million NIH small business innovation research (SBIR) grant

Award from the National Institute of Diabetes and Digestive…

Beta Bionics secures an initial $50 million Series B round

The round was led by Eventide Asset Management Other institutional…

Beta Bionics Announces iLet Bionic Pancreas is Now Added to the Express Scripts National Commercial Formularies

/
CONCORD, Mass., November 14, 2023: Beta Bionics, Inc., a pioneering…

Beta Bionics Secures $100 Million in Series D Funding to Advance Diabetes Technology and Expand Market Presence

/
CONCORD, Mass., August 30, 2023: Beta Bionics, Inc., a pioneering…

Beta Bionics Announces FDA Clearance and Commercialization of the iLet Bionic Pancreas

- First and only, automated insulin-delivery system that determines…

Beta Bionics Appoints Sean Saint as CEO and Board Member

Caution: The iLet® Bionic Pancreas and iLet Duo™ are investigational…

Pivotal Trial Results of the iLet® Bionic Pancreas To Be Presented at ATTD

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Announces Closing of $57 Million Series C Financing

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Announces Appointment of Christy Jones to Board of Directors

Irvine, CA – May 6, 2021 – Beta Bionics, Inc., a medical…

Beta Bionics appoints Beth Brooke to its Board as Independent Director

Concord, MA – December 30, 2020 – Beta Bionics, Inc. —…

Beta Bionics appoints Martha Aronson and Sean Carney to its Board as Independent Directors

West Concord, MA – February 20, 2020 – Beta Bionics, Inc.…

Beta Bionics awarded up to $2 million NIH small business innovation research (SBIR) grant

Award from the National Institute of Diabetes and Digestive…

Beta Bionics secures an initial $50 million Series B round

The round was led by Eventide Asset Management Other institutional…

Beta Bionics Announces iLet Bionic Pancreas is Now Added to the Express Scripts National Commercial Formularies

/
CONCORD, Mass., November 14, 2023: Beta Bionics, Inc., a pioneering…

Beta Bionics Secures $100 Million in Series D Funding to Advance Diabetes Technology and Expand Market Presence

/
CONCORD, Mass., August 30, 2023: Beta Bionics, Inc., a pioneering…

Beta Bionics Announces FDA Clearance and Commercialization of the iLet Bionic Pancreas

- First and only, automated insulin-delivery system that determines…

Beta Bionics Appoints Sean Saint as CEO and Board Member

Caution: The iLet® Bionic Pancreas and iLet Duo™ are investigational…

Pivotal Trial Results of the iLet® Bionic Pancreas To Be Presented at ATTD

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Announces Closing of $57 Million Series C Financing

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Announces Appointment of Christy Jones to Board of Directors

Irvine, CA – May 6, 2021 – Beta Bionics, Inc., a medical…

Beta Bionics appoints Beth Brooke to its Board as Independent Director

Concord, MA – December 30, 2020 – Beta Bionics, Inc. —…

Beta Bionics appoints Martha Aronson and Sean Carney to its Board as Independent Directors

West Concord, MA – February 20, 2020 – Beta Bionics, Inc.…

Beta Bionics awarded up to $2 million NIH small business innovation research (SBIR) grant

Award from the National Institute of Diabetes and Digestive…

Beta Bionics secures an initial $50 million Series B round

The round was led by Eventide Asset Management Other institutional…

Beta Bionics Announces iLet Bionic Pancreas is Now Added to the Express Scripts National Commercial Formularies

/
CONCORD, Mass., November 14, 2023: Beta Bionics, Inc., a pioneering…

Beta Bionics Secures $100 Million in Series D Funding to Advance Diabetes Technology and Expand Market Presence

/
CONCORD, Mass., August 30, 2023: Beta Bionics, Inc., a pioneering…

Beta Bionics Announces FDA Clearance and Commercialization of the iLet Bionic Pancreas

- First and only, automated insulin-delivery system that determines…

Beta Bionics Appoints Sean Saint as CEO and Board Member

Caution: The iLet® Bionic Pancreas and iLet Duo™ are investigational…

Pivotal Trial Results of the iLet® Bionic Pancreas To Be Presented at ATTD

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Announces Closing of $57 Million Series C Financing

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Announces Appointment of Christy Jones to Board of Directors

Irvine, CA – May 6, 2021 – Beta Bionics, Inc., a medical…

Beta Bionics appoints Beth Brooke to its Board as Independent Director

Concord, MA – December 30, 2020 – Beta Bionics, Inc. —…

Beta Bionics appoints Martha Aronson and Sean Carney to its Board as Independent Directors

West Concord, MA – February 20, 2020 – Beta Bionics, Inc.…

Beta Bionics awarded up to $2 million NIH small business innovation research (SBIR) grant

Award from the National Institute of Diabetes and Digestive…

Beta Bionics secures an initial $50 million Series B round

The round was led by Eventide Asset Management Other institutional…

Beta Bionics Announces iLet Bionic Pancreas is Now Added to the Express Scripts National Commercial Formularies

/
CONCORD, Mass., November 14, 2023: Beta Bionics, Inc., a pioneering…

Beta Bionics Secures $100 Million in Series D Funding to Advance Diabetes Technology and Expand Market Presence

/
CONCORD, Mass., August 30, 2023: Beta Bionics, Inc., a pioneering…

Beta Bionics Announces FDA Clearance and Commercialization of the iLet Bionic Pancreas

- First and only, automated insulin-delivery system that determines…

Beta Bionics Appoints Sean Saint as CEO and Board Member

Caution: The iLet® Bionic Pancreas and iLet Duo™ are investigational…

Pivotal Trial Results of the iLet® Bionic Pancreas To Be Presented at ATTD

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Announces Closing of $57 Million Series C Financing

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Announces Appointment of Christy Jones to Board of Directors

Irvine, CA – May 6, 2021 – Beta Bionics, Inc., a medical…

Beta Bionics appoints Beth Brooke to its Board as Independent Director

Concord, MA – December 30, 2020 – Beta Bionics, Inc. —…

Beta Bionics appoints Martha Aronson and Sean Carney to its Board as Independent Directors

West Concord, MA – February 20, 2020 – Beta Bionics, Inc.…

Beta Bionics awarded up to $2 million NIH small business innovation research (SBIR) grant

Award from the National Institute of Diabetes and Digestive…

Beta Bionics secures an initial $50 million Series B round

The round was led by Eventide Asset Management Other institutional…

Beta Bionics Announces iLet Bionic Pancreas is Now Added to the Express Scripts National Commercial Formularies

/
CONCORD, Mass., November 14, 2023: Beta Bionics, Inc., a pioneering…

Beta Bionics Secures $100 Million in Series D Funding to Advance Diabetes Technology and Expand Market Presence

/
CONCORD, Mass., August 30, 2023: Beta Bionics, Inc., a pioneering…

Beta Bionics Announces FDA Clearance and Commercialization of the iLet Bionic Pancreas

- First and only, automated insulin-delivery system that determines…

Beta Bionics Appoints Sean Saint as CEO and Board Member

Caution: The iLet® Bionic Pancreas and iLet Duo™ are investigational…

Pivotal Trial Results of the iLet® Bionic Pancreas To Be Presented at ATTD

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Announces Closing of $57 Million Series C Financing

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Announces Appointment of Christy Jones to Board of Directors

Irvine, CA – May 6, 2021 – Beta Bionics, Inc., a medical…

Beta Bionics appoints Beth Brooke to its Board as Independent Director

Concord, MA – December 30, 2020 – Beta Bionics, Inc. —…

Beta Bionics appoints Martha Aronson and Sean Carney to its Board as Independent Directors

West Concord, MA – February 20, 2020 – Beta Bionics, Inc.…

Beta Bionics awarded up to $2 million NIH small business innovation research (SBIR) grant

Award from the National Institute of Diabetes and Digestive…

Beta Bionics secures an initial $50 million Series B round

The round was led by Eventide Asset Management Other institutional…